Reports for SANDOZ CANADA INCORPORATED

Company Name

SANDOZ CANADA INCORPORATED

Totals

Shortage reports

2271

Actual shortage: 53 (2%)
Anticipated shortage: 0 (0%)
Avoided shortage: 19 (1%)
Resolved: 2199 (97%)

Discontinuation Reports

124

To be discontinued: 4 (3%)
Discontinued: 118 (95%)
Reversed: 2 (2%)

Late reports

452 (19%)

Overdue reports

11 (19%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
SANDOZ DORZOLAMIDE 2% SOLUTION Resolved 2024-10-07 2024-10-22 239585
SANDOZ DORZOLAMIDE 2% SOLUTION Resolved 2025-05-05 2025-05-16 256683
SANDOZ DORZOLAMIDE/TIMOLOL 5MG 20MG SOLUTION Resolved 2017-09-07 2017-10-25 21357
SANDOZ DORZOLAMIDE/TIMOLOL 5MG 20MG SOLUTION Resolved 2019-01-16 2020-06-15 72487
SANDOZ DORZOLAMIDE/TIMOLOL 5MG 20MG SOLUTION Resolved 2023-05-08 2023-05-25 191999
SANDOZ DORZOLAMIDE/TIMOLOL 5MG 20MG SOLUTION Resolved 2024-07-08 2024-11-19 232471
SANDOZ DORZOLAMIDE/TIMOLOL 20MG 5MG SOLUTION Actual shortage 2025-11-03 2025-11-17 270827
SANDOZ DULOXETINE 30MG CAPSULE (DELAYED RELEASE) Resolved 2017-11-13 2017-11-27 29105
SANDOZ DULOXETINE 30MG CAPSULE (DELAYED RELEASE) Resolved 2018-02-15 2018-07-03 39990
SANDOZ DULOXETINE 60MG CAPSULE (DELAYED RELEASE) Resolved 2018-02-15 2018-05-07 39993
SANDOZ DULOXETINE 30MG CAPSULE (DELAYED RELEASE) Resolved 2023-03-06 2023-03-14 186281
SANDOZ DULOXETINE 30MG CAPSULE (DELAYED RELEASE) Resolved 2023-10-16 2024-01-17 207079
SANDOZ DULOXETINE 30MG CAPSULE (DELAYED RELEASE) Resolved 2024-02-12 2024-04-03 219220
SANDOZ DULOXETINE 60MG CAPSULE (DELAYED RELEASE) Resolved 2025-09-02 2025-09-16 266297
SANDOZ DULOXETINE 30MG CAPSULE (DELAYED RELEASE) Actual shortage 2025-09-08 2025-09-09 266731
SANDOZ DULOXETINE 60MG CAPSULE (DELAYED RELEASE) Actual shortage 2025-12-08 2025-12-09 273758
SANDOZ DUTASTERIDE 0.5MG CAPSULE Actual shortage 2025-11-17 2025-11-18 271991
SANDOZ DUTASTERIDE 0.5MG CAPSULE Resolved 2017-03-14 2017-09-07 2702
SANDOZ DUTASTERIDE 0.5MG CAPSULE Resolved 2017-03-15 2017-09-06 2884
SANDOZ DUTASTERIDE 0.5MG CAPSULE Resolved 2017-04-04 2017-09-06 5573

Showing 961 to 980 of 2271

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ALFENTANIL INJECTION USP Discontinued 2019-10-15 2019-10-15 96610
ATRACURIUM BESYLATE INJECTION Discontinued 2019-10-15 2019-10-15 96613
BETAJECT Discontinued 2019-10-15 2019-10-15 96616
BLUE COLLYRIUM Discontinued 2019-10-15 2019-10-15 96619
BRETYLIUM TOSYLATE INJECTION USP 50MG SOLUTION Discontinued 2017-12-06 2017-12-06 31958
BRETYLIUM TOSYLATE INJECTION USP Discontinued 2020-04-01 2020-04-01 110288
CLINDAMYCIN INJECTION USP 150MG LIQUID Discontinued 2017-06-06 2017-10-18 12122
CODEINE PHOSPHATE INJECTION USP 30MG LIQUID Discontinued 2022-04-20 2022-04-20 159064
COMTAN 200MG TABLET Discontinued 2022-03-03 2022-03-04 155940
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Discontinued 2018-08-27 2019-01-02 59179
FOLIC ACID INJECTION USP 5MG LIQUID To be discontinued 2019-05-01 2019-05-01 82956
FOLIC ACID INJECTION USP 5MG LIQUID Discontinued 2020-01-28 2020-01-28 104481
HEPARIN SODIUM INJECTION USP (SINGLE USE VIAL-PRESERVATIVE FREE) 10000UNIT SOLUTION Discontinued 2018-07-04 2018-07-31 54349
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 10000UNIT SOLUTION Discontinued 2023-10-18 2023-10-19 207275
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 10000UNIT SOLUTION Discontinued 2024-05-17 2024-05-18 228249
IMIPENEM AND CILASTATIN FOR INJECTION USP 250MG 250MG POWDER FOR SOLUTION Discontinued 2021-08-23 2021-08-23 144467
KETOROLAC TROMETHAMINE INJECTION USP 30MG SOLUTION LIQUID Discontinued 2025-08-04 2025-08-05 264341
LORAZEPAM INJECTION USP 2MG SOLUTION Discontinued 2020-02-14 2020-03-12 106265
MICRO PLUS 6 (CONCENTRATE) 75MCG 60MCG 10MCG 0.5MG 1MG 5MG LIQUID Discontinued 2021-10-25 2021-10-26 147927
MILRINONE LACTATE INJECTION 1MG SOLUTION Discontinued 2022-06-17 2022-06-18 163000

Showing 1 to 20 of 124